ATLANTA, GA – – (Newsfile Corp. – October 6, 2021) – – Holzer & Holzer, LLC is investigating whether Ginkgo Bioworks Holdings, Inc. (“Ginkgo” or the “Company”) (NYSE: DNA) complied with federal securities laws. On October 6, 2021, Scorpion Capital released a report alleging, among other things, the Company is highly dependent on related party transactions. On this report, the price of the Company’s stock declined. If you purchased Ginkgo stock and suffered a substantial loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com to discuss your legal rights.

Provide Your Information To Take Action

  • Date PurchasedNumber of Shares AcquiredAcquisition Price Per Share 
  • Date SoldNumber of Shares SoldSelling Price Per Share 
  • Signed pursuant to the Uniform Electronic Transactions act as adopted by the various states and territories of the United States.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt